May 312013
Introduction of a sulfoximine group into anticancer candidates shows that sometimes sticking to the unconventional pays off
Introduction of a sulfoximine group into anticancer candidates shows that sometimes sticking to the unconventional pays off
Sorry, the comment form is closed at this time.